Endra Life Sciences touts preliminary TAEUS liver fat analysis study data

Endra Life Sciences today reported preliminary results from the first-in-man feasibility study of its Thermo Acoustic Enhanced Ultrasound System exploring its ability to measure and analyze liver fat. The TAEUS platform is designed to allow for the visualization of human tissue composition, function and temperature at a cheaper cost than computed tomography or magnetic resonance imaging and provided at the point-of-care, the Ann Arbor, Mich.-based company said. Preliminary data came from 25 subjects analyzed with the TAEUS platform as compared with quantitative MRI fat fraction measurements and other indicators including Body Mass Index and abdominal fat thickness as measured by traditional ultrasound. Results from the trial indicated that 21 subjects in the study had less than 6% liver fat fraction as assessed by MRI, classified in the healthy or normal range, while the other four subjects were found to have between 8% and 22.4% fat fraction, which is classified as mild non-alcoholic fatty liver disease. Study investigators said that the correlation between thermoacoustic measurements of Endra’s reference designed and the percent fat fraction as measured by MRI had an R2 of 0.61 with a standard error of the mean of 2.98%. Correlations between BMI with MRI fat fraction were only 0.19, while the correlation of abdominal fat thickness analyzed via ultrasound and MRI fat fraction was 0.31, the company said. Endra said that some subjects in the trial with ‘mild’...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Imaging endralifesciences Source Type: news